Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

British Journal of Cancer

Volumn 81, Issue 8, 1999, Pages 1274-1279

  Tomozawa, S ^a   Nagawa, H ^a   Tsuno, N ^a   Hatano, K ^a   Osada, T ^a   Kitayama, J ^a   Sunami, E ^a   Nita, M E ^a   Ishihara, S ^a   Yano, H ^a   Tsuruo, T ^a   Shibata, Y ^a   Muto, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Colon cancer; COX 2; Metastasis; MMP; Selective COX 2 inhibitor

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; TILMACOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; LUNG WEIGHT; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ZYMOGRAPHY;

EID: 0032758506     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6694262     Document Type: Article

References (37)

1. Chamber AF and Matrysian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270
2. DuBois RN, Awad J, Morrow J, Roberts LJ and Bishop PR (1994) Regulation of cicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor and phorbol ester. J Clin Inves 93: 493-498
3. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN (1994) Up-regulalion of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188
4. Elder DJE, Halton DE, Hague A and Paraskeva C (1997) Induction of apoptotic cell death in human coloreclal carcinonia cell lines by a cyclooxygenase-2 (COX 2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 3: 1679-1683
5. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
6. 2, and angiogenesis. Prog Soc Exp Biol Med 172: 214-218
7. Fujimoto-Ouchi K, Tamura S, Mori K, Tanaka Y and Ishitsuka H (1995) Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma. Int J Cancer 61: 522-528
8. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A and Willett WC (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241-246
9. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC and Speizer FE (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614
10. Hara A, Yoshimi N, Niwa M, Ino N and Mori H (1997) Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn J Cancer Res 88: 600-604
11. Hasegawa M, Arai T and Ihara Y (1990) Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease. Neuron 4: 909-918
12. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K and Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
13. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA and Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049-9054
14. Kargman SL, O'Neil GP, Vickers PJ, Evans JF, Mancini JA and Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559
15. Kato N, Nawa A, Tamakoshi K, Kikkawa F, Suganuma N, Okamoto T, Goto S, Tomoda Y, Hamaguchi M and Nakajima M (1995) Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta. Am J Obstet Gynecol 172: 601-606
16. Kawamori K, Rao CV, Seibert K and Reddy BSC (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-412
17. Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschmann HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266: 12866-12872
18. Liotta LA, Rao CN and Wewer UM (1986) Biochemical interactions with the basement membranes. Annu Rev Biochem 55: 1037-1057
19. Mahadevan V and Hart IR (1990) Metastasis and angiogenesis. Acta Oncol 29: 97-103
20. Majima M, Isono M, Ikeda Y, Hayashi I, Hatanaka K, Harada Y, Katsumata O, Yamashita S, Katori M and Yamamoto S (1997) Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn J Pharmacol 75: 105-114
21. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
22. Marnett LJ (1995) Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev Med 24: 103-106
23. Matsushita M, Masaki M, Yagi Y, Tanaka T and Wakitani K (1997) Pharmacological profile of JTE 522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm Res 46: 461-466
24. O'Banion MK, Sadowsky HB, Winn V and Young DA (1991) A serum and glucocorticoíd-related 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266: 23261-23267
25. A716 knockout mice by inhibition of cylooxygenase-2 (COX-2), Cell 87: 803-809
26. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukeu R and Ahnen DJ (1997) Apoptosis primarily accounts for the growth-inhibitory properties of sulindue metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57: 2452-2459
27. Reddy BS, Rao CV and Seibert K (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56: 4566-4569
28. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M and Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789
29. Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville-Nash PR, Willis D, Somerville KW, Asculai S and Willoughby DA (1997) The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenae in 2.5% hyaluronan. Cancer Res 57: 1625-1629
30. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RJ and DuBois RN (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254-2259
31. Thun MJ, Namboodiri MM and Heath CWJ (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596
32. Thun MJ, Namboodiri MM, Calle EE, Flanders WD and Heath CWJ (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327
33. Tsuji M, Kawano S and DuBois RN (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340
34. Tsujii M, Kawano S, Tsuji S, Sawaoku H, Hori M and DuBois RN (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716
35. Williams CW and DuBois RN (1996) Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270: G393-G400
36. Xie W and Herschman HR (1995) v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 270: 27622-27628
37. 1, and copper in angiogenesis. J Natl Cancer Inst 69: 475-482.